All Stories

  1. The Experience with Biosimilars of Infliximab in Rheumatic Diseases

    Article • Current Pharmaceutical Design, February 2018, Bentham Science Publishers

    valderilio azevedo

  2. Adalimumab: a review of the reference product and biosimilars

    Article • Biosimilars, July 2016, Dove Medical Press

    valderilio azevedo

  3. Apoptosis and the FLIP and NF-kappa B proteins as pharmacodynamic criteria for biosimilar TNF-alpha antagonists

    Article • Biologics Targets and Therapy, July 2014, Dove Medical Press

    valderilio azevedo, Vanete Soccol